LOADING
Tag: BMS986104
BMS-986104 by Bristol-Myers Squibb for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
November 3, 2023
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. BMS-986104 overview BMS-986104 is under development for the treatment of atopic […]
chat_bubble0 Comment
visibility253 Views